# XTAMPZA ER

NDC: 24510-120
Generic name: OXYCODONE
Labeler / Manufacturer: Collegium Pharmaceutical, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20160510

FDA application: NDA208090

## Active ingredients

- OXYCODONE: 18 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24510-120"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24510-120
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c